Cryoablation vendor Endocare has been approved for listing on the Nasdaq stock exchange.
The Irvine, CA-based company will begin trading on October 10 under the ticker symbol ENDO. Endocare believes the move will help attract a broader audience of potential investors and provide more liquidity and enhanced stockholder value over time.
By AuntMinnie.com staff writers
October 9, 2007
Related Reading
Endocare 2006 revenues slip due to divestiture, March 9, 2007
Endocare gets 510(k) for cryoablation device, September 12, 2006
Cryoablation provides effective palliation for bone metastasis, April 4, 2005
Endocare to showcase Percryo probes, November 14, 2003
Endocare brings Cryocare to market, August 21, 2003
Copyright © 2007 AuntMinnie.com